CDK9 Antikörper
-
- Target Alle CDK9 Antikörper anzeigen
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CDK9 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC)
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human CDK9 (NP_001252.1).
- Isotyp
- IgG
- Top Product
- Discover our top product CDK9 Primärantikörper
-
-
- Applikationshinweise
- IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
- Andere Bezeichnung
- CDK9 (CDK9 Produkte)
- Hintergrund
- The protein encoded by this gene is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. This kinase was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS.
- Molekulargewicht
-
Observed_MW: 45kDa
Calculated_MW: 42kDa/53kDa
- Gen-ID
- 1025
- UniProt
- P50750
- Pathways
- Zellzyklus
-